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ABSTRACT: While the importance of viral infections is well studied in domestic cats, only limited
information is available on their occurence and prevalence in the European wildcat (Felis silvestris
silvestris). The aim of this study was to determine the prevalence of antibodies to feline coro-
navirus (FCoV), calicivirus (FCV), herpesvirus (FHV), parvovirus (FPV), immunodeficiency virus
(FIV), leukemia virus (FeLV), and FeLV antigenemia in 51 European wildcat sera. Samples were
collected between 1996 and 1997 from wildcat populations in France, Switzerland, and Germany.
Antibodies to FCoV were detected in two cats (4%) and FCoV RNA was detected in feces of
one of these two cats. Antibodies to FCV, FHV and FPV were found at relatively low frequencies
of 16%, 4%, and 2%, respectively. Antibodies to FIV were not detected. Although antigen and
antibodies to FeLV were detected in 49%, and 75%, respectively, no evidence of FeLV-associated
pathology was found. From the low prevalence of FCoV, FCV, FHV and FPV infections and
from the fact that the European wildcats live solitarily, it was concluded that these viral infections
do not spread readily within a population. Therefore, it may be assumed that release into the
wild of European wildcats bred in captivity would not bring about a high risk of introducing of
these viral infections to the free-ranging wildcats. As an exception, wildcats should be tested for
absence of FIV infection before release if they were at risk to acquire this infection from domestic
cats.
Key words: European wildcat, feline calicivirus, feline coronavirus, feline herpesvirus, feline
immunodeficiency virus, feline infectious peritonitis, feline leukemia virus, feline parvovirus, Felis
silvestris silvestris, serosurvey.
INTRODUCTION
The European wildcat (Felis silvestris
silvestris) is a threatened species in Eu-
rope and according to the CITES agree-
ment (Goldsmith, 1978) capture and trade
of animals and parts thereof are highly re-
stricted. Survival of European wildcat pop-
ulations has been aided by release of wild-
cats bred in captivity into the wild (Bu¨tt-
ner, 1994), but there are few published re-
ports about the prevalence and possible
pathogenic aspects of viral infections in
these populations (Artois and Remond,
1994; Boid et al., 1991; McOrist et al.,
1991).
Several viruses of domestic cats are
known to exist also in nondomestic felid
populations: feline coronavirus (FCoV), fe-
line calicivirus (FCV), feline viral rhinotra-
cheitis virus (feline herpesvirus, FHV), fe-
line panleukopenia virus (feline parvovi-
rus, FPV), and feline immunodeficiency
virus (FIV) (Paul-Murphy et al., 1994;
Spencer, 1991; Hofmann-Lehmann et al.,
1996; Olmsted et al., 1992; Lutz et al.,
1992). Only feline leukemia virus (FeLV)
is not regularly found in free-ranging wild
felids. Some of the reports of FeLV infec-
tion in wild felids may be explained by
close contacts with domestic cats (Meric,
1984; Jessup et al., 1993).
In domestic cats, infection with feline
coronavirus (FCoV) occurs worldwide and
eventually may lead to a lethal disease
called feline infectious peritonitis (FIP).
Antibodies to FCoV are present in 80 to
90% of the cats in catteries and in 10 to
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50% of single-cat households (Addie and
Jarrett, 1992; Sparkes et al., 1992; Herrew-
egh et al., 1995; Pedersen, 1976; Fehr et
al., 1997). Up to 5 to 10% of seropositive
cats die of FIP (Addie and Jarrett, 1992;
Pedersen, 1976; Fehr et al., 1997) and it
is believed that factors such as suscepti-
bility, age, stress, and virus load influence
the outcome of an infection with FCoV.
Infection with FCoV leading to FIP has
also been reported to have devastating ef-
fects in some wild felids kept in captivity;
FIP cases have been reported mainly in
cheetahs but also in African lions (Panth-
era leo), leopards (Panthera pardus),
mountain lions (Felis concolor), lynx (Lynx
lynx), caracal (Felis caracal), and smaller
wildcats (Colby and Low, 1970; Evermann
et al., 1983; Quensberry, 1984; Van Rens-
burg and Silkstone, 1984). FCoV has re-
cently been reported in free-ranging Scot-
tish European wildcats (Felis silvestris sil-
vestris) (Daniels et al., 1999), and out-
breaks have been described in two closed
colonies of European wildcats (Lutz et al.,
1996; Watt et al., 1993).
Feline calicivirus (FCV) and feline her-
pesvirus (FHV) are agents causing mainly
upper respiratory tract diseases. FCV in
most instances is responsible for stomati-
tis, gingivitis, and glossitis. Clinical signs of
rhinotracheitis have been described in
wildcats from Scotland (McOrist et al.,
1991) and serological evidence of FCV in-
fections was detected in wildcats from
eastern France (Artois and Remond,
1994).
Feline parvovirus (FPV) is a highly con-
tagious virus prevalent in most members
of the family Felidae. It induces an acute
disease characterized by leukopenia, fever,
depression, dehydration, diarrhea, and
death in domestic cats. A majority of the
free-ranging mountain lions in California
(93%; Paul-Murphy et al., 1994), the Af-
rican lions in Kruger National Park (84%;
Spencer, 1991) as well as the lions in the
Serengeti and Ngorongoro Crater had an-
tibodies to FPV (Hofmann-Lehmann et
al., 1996). Antibodies to FPV occasionally
could be found in European wildcats but
due to low numbers of examined samples,
a reliable prevalence estimate could not be
determined (Artois and Remond, 1994).
Feline immunodeficiency virus (FIV)
infection is associated with a progressive
immunosuppression and leads to oppor-
tunistic infections in domestic cats. Viruses
closely related to the FIV of domestic cats
occur also in nondomestic felid species:
members of at least 18 of the 37 species
in the family Felidae carry an FIV-related
virus as has been shown by the presence
of antibodies in their sera crossreacting
with FIV antigen (Hofmann-Lehmann et
al., 1996; Olmsted et al., 1992; Brown et
al., 1994; Carpenter and O’Brien, 1995;
Lutz et al., 1992). Currently, FIV is not
considered to be present in the European
wildcat (Artois and Remond, 1994; Mc-
Orist et al., 1991; McOrist, 1992).
Feline leukemia virus (FeLV), an exog-
enous retrovirus that is transmitted hori-
zontally and vertically among domestic
cats, causes neoplastic diseases including
lymphosarcoma and leukemia, aplastic
anemia and immunosuppression in the do-
mestic cat (Jarrett et al., 1964). This virus
has consistently been found in the Euro-
pean wildcat. It was detected at a preva-
lence of 9% in a UK population (Boid et
al., 1991; McOrist, 1992) and at 40% in
the eastern France population (Artois and
Remond, 1994). Reports on FeLV in ex-
otic felids have been based on positive an-
tigen-tests in occasionally captive animals
(Boid et al., 1991; Meric, 1984; Citino,
1986), the isolation of the virus from a
leopard cell line (Rasheed and Gardner,
1981) and from an European wildcat in
Scotland (Boid et al., 1991). Furthermore,
Jessup et al. (1993) described a FeLV-pos-
itive cougar which might have acquired
the infection from a FeLV positive domes-
tic cat, based on being found in a city.
It was the goal of the present study to
determine the prevalence and the possible
biological importance of viral infections in
European wildcat populations in central
eastern France, Germany, and Switzerland.
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MATERIALS AND METHODS
Population structure
The wildcats in France and Switzerland are
part of autochthonous populations, whereas the
animals in Germany are captive bred and later
released into the wild through the reintroduc-
tion program in Bavaria. This species is covered
by the CITES agreement as it is considered a
threatened species. However, no information is
available on the number of animals living in the
different habitats and the true density of the
population is unknown. Cats were defined as
wildcats by phenotypical assessment (i.e., size
of the skull) and also according to anatomical
criterias (i.e., length of intestine; Schauenberg,
1977; Piechocki, 1986).
Animals and sampling of blood and feces
Blood (heart clot) and fecal samples were
obtained from 9 wildcats found dead in the
Swiss Jura formation (478009N, 68959W) from
1996 to 1997. Bodies were immediately frozen
after collection. Blood and fecal samples were
collected after thawing at necropsy, and the
samples were immediately frozen, transported
on dry ice and stored at 280 C until tests were
performed.
In addition, blood samples were collected
from 34 wildcats in France which had been hit
by car between March 1995 and October 1996.
Collected animals were frozen at 230 C and
stored for one to several weeks. Blood and fecal
samples were collected as described above. Af-
ter thawing, the blood samples were centri-
fuged at 15,000 3 g for 20 min at 4 C to re-
move cell debris, and used for serological as-
says.
Eight serum samples were obtained from
anesthetized subadult wildcats bred in captivity,
which were to be released by the German re-
lease program in Wiesenfelden near Straubing
(Bavaria, Germany, 488539N, 128349W).
Serology
Antibodies to FCoV, FCV, FHV, and FPV
were detected by immunofluorescence assay
(IFA). The substrate for the FCoV assay was
TGEV in crandell feline kidney cells (CrFK)
cells (Lutz et al., 1985; Osterhaus et al., 1977),
for calicivirus CrFK infected with FCV (Swiss
strain, kindly provided by Veterinaria, Zurich,
Switzerland), for the FHV assay CrFK infected
with FHV (Swiss strain, kindly provided by Ve-
terinaria, Zurich, Switzerland; Hofmann-Leh-
mann et al., 1996), for the FPV assay CrFK
infected with a Swiss strain of FPV (Hofmann-
Lehmann et al., 1996). All IFAs were tested at
dilutions of 1:25, 1:100, 1:400, 1:1600. The con-
jugate was goat anti-cat FITC (KPL, Gaithers-
burg, Maryland, USA).
Antibodies to the transmembrane (TM) pro-
tein of FIV were detected by enzyme-linked
immunosorbent assay (ELISA) as described
(Calzolari et al., 1995) and by Western blot
(Lutz et al., 1988).
Antibodies to FeLV gp70 were detected by
ELISA described elsewhere (Lutz et al., 1980).
Viral detection
A nested RT-PCR was carried out as de-
scribed (Fehr et al., 1996) amplifying a highly
conserved 39-untranslated region (39-UTR) of
the FCoV genome.
The serum samples were tested for presence
of FeLV p27 by a double-antibody sandwich
ELISA based on monoclonal antibodies (Lutz
et al., 1983).
Sensitivity tests
Due to the freezing process, serum samples
collected from dead animals were hemolyzed.
In order to determine whether and to what de-
gree the hemolysis affected the serological as-
says, 30 whole blood domestic cat samples were
tested. The initial serological tests were done
using EDTA plasma. In order to obtain he-
molytic samples, aliquots of the same whole
blood samples were subjected to one freeze-
thaw cycle, centrifuged, and serologic tests for
FCoV, FCV, FHV, and FPV antibodies were re-
peated.
In order to determine whether hemolysis
was responsible for positive FeLV p27 ELISA
results, p27 antigen was immune-complexed,
precipitated with polyethylene glycol (PEG
6000, Fluka, Buchs, Switzerland) and tested in
Western blot. The experiments were carried
out using the following volumes and reagents:
to 100 ml of the hemolytic wildcat blood and of
a FeLV positive domestic cat blood serving as
a positive control, 20 ml of a polyclonal goat
serum specific for FeLV p27 (serum no. 78-S;
National Cancer Institute, Bethesda, Maryland,
USA) were added. Forty ml of 10% polyethyl-
ene glycol buffer (5 g polyethylene glycol 6000
in a total of 50 ml phosphate buffered saline)
were added to 100 ml each of the hemolytic
blood samples of these cats. The anti p27 se-
rum and the hemolytic blood samples were in-
cubated in a rotatory shaker for three hours at
37 C; incubation was continued at 4 C over-
night. Tubes were centrifuged (10,000 3 g at 4
C) and the resulting pellets were washed three
times in 1.5 ml 2.5% PEG wash solution (10
mM Tris-HCl, pH 7.2, 25 mM sodium borate,
140 mM NaCl, 10 mM Na-EDTA, 2.5% PEG
6000) and centrifuged as above. The final pel-
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FIGURE 1. Effect of hemolysis in serum samples
from the European wildcat on the performance of the
FCV, FHV, FPV and FCoV (see text for abbreviation)
immunofluorescence assays.
lets were dried in a nitrogen stream and solu-
bilized in 50 ml of 6 M urea. After addition of
5 ml of 4 3 SDS sample buffer, the samples
were heated for 5 min at 95 C and loaded on
a 10% polyacrylamide gel. Proteins were blot-
ted to a nitrocellulose sheet and inubated with
a mixture of monoclonal antibodies to p27 con-
jugated to peroxidase (10 ml/ml) or a polyclonal
anti FeLV p27 serum (as used above) conju-
gated to peroxidase. Detection of an antigenic
band of 27,000 da on the Western blot strip by
monoclonal antibodies to p27 was considered
proof for the presence of FeLV p27 in the he-
molyzed samples.
RESULTS
Sensitivity tests
In the FPV IFA, 15 of 30 (50%) samples
tested positive with hemolytic samples,
whereas 18 of 30 (60%) samples tested
positive with nonhemolytic plasma sam-
ples. For the FPV IFA, there was a 10%
loss of sensitivity. Similar results were ob-
tained for FCoV (10% loss of sensitivity),
FCV (8% gain of sensitivity), and FHV
(7% loss of sensitivity). For details see Fig-
ure 1. From these experiments it was con-
cluded that the use of hemolyzed blood
samples would result in slightly decreased
numbers of positive tested samples, in the
case of FCV with unchanged or even
slightly increased numbers of samples test-
ed positive for FCV compared with the
use of non-hemolytic plasma.
Performance of the FPV IFA assay and of FeLV
p27 ELISA
Seventeen plasma samples from domes-
tic cats vaccinated twice against FPV prior
to the IFA were tested for antibodies to
parvovirus as described above. One of
them was seronegative, five showed a titer
of 80, one had a titer of 160, four a titer
of 320, five a titer of 1,500, and one a titer
of 2,000.
The specificity of the FeLV p27 antigen
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ELISA was confirmed by precipitating p27
antigen in four of four hemolytic blood
samples of the wildcats that were positive
for p27 by ELISA. At the same time, two
serum samples from FeLV negative spf
cats were clearly negative for p27 by West-
ern blot analysis of the PEG precipitated
immune complexes.
Prevalence of antibodies to FCoV, FCV, FIV, FHV,
FeLV and FPV
The prevalences of antibodies to FCoV,
FCV, FIV, FHV, FeLV and FPV were as
follows (Table 1): two of the 51 cats (4%)
tested positive for FCoV. Both FCoV an-
tibody positive cats were wildcats without
evident signs of preexisting disease. Eight
of the 51 (16%) tested samples showed an-
tibodies to FCV: five cats of the French
population, two cats from the wildcats
from Germany, and one cat from the Swiss
population. No antibodies to FIV could be
detected in any of the 51 tested serum
samples. Antibodies against FHV were
found in two wildcats (4%). Twenty-five of
the 51 samples (49%) tested positive for
antibodies to FeLV. One cat (2%) showed
antibodies to FPV.
Detection of FCoV RNA and FeLV antigen
Fecal samples from all cats of the Swiss
and 26 cats of the French wildcat popu-
lation were analyzed by RT-PCR to detect
FCoV RNA. The animal from the French
population with a titer of 100 by FCoV
IFA was also positive by RT-PCR. All oth-
er cats were negative in their feces (98%).
FeLV p27 antigen was detected in 77% of
all serum samples.
DISCUSSION
Some of the samples used in this study
originated from cats which had been ex-
posed to decay for an unknown duration.
In view of the fact that antibodies are
known to be quite resistant to proteolytic
degradation (Bazin et al., 1994), we spec-
ulate that no loss in titers have to be ex-
pected within 48 hr after death of the
French wildcats which was considered to
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be the patrol interval of the inspection
tours. The situation of cats collected in
Switzerland is somewhat different because
time between death and recovering cannot
be estimated. However, 5 of 9 cats were
found during wintertime. The fact that five
of nine cats collected in Switzerland had
antibodies to FeLV supports our assump-
tion that antibodies were still active. The
serological tests of this study had to be
done with hemolytic samples. The results
showed that hemolysis leads to a decrease
of sensitivity of less than one titer-step cor-
responding to the volume displacement ef-
fect caused by the red cells present in the
blood samples (hematocrit, 30–40%). In
consideration of the above mentioned ex-
periments we may have underestimated
the true prevalence of the infections.
However, the misjudgment may not ex-
ceed 10%.
The FCoV results are in contrast to the
situation of the domestic cat, where an an-
tibody prevalence of 50 to 90% can be de-
tected (Pedersen, 1976; Fehr et al., 1997).
In contrast to the domestic cat, free-living
wildcats are living as a dispersed social sys-
tem. As contacts between individual wild-
cats occur mainly in connection with mat-
ing (Parent, 1975) and at low frequency, a
decreased risk to spread infectious diseas-
es can be postulated. It was shown that in
domestic cats, FCoV infection can be con-
trolled if the number of cats living in a
confined area is reduced (Addie and Jar-
rett, 1992). The fact, that FCoV infection
is present at low prevalence in the Euro-
pean wildcat is therefore in agreement
with the observation made by Addie and
Jarrett (1992). Even if asymptomatic wild-
cats exist as FCoV carriers, as was de-
scribed for domestic cats (Addie and Jar-
rett 1992; Pedersen, 1987), they are only
able to spread the virus in a limited area
and to a low number of other wildcats.
The two FIP outbreaks in closed colonies
showed that European wildcats kept under
captive conditions that imply an unecolog-
ical crowding are also susceptible to FCoV
infection and FIP. This situation is very
similar to that of the domestic cat; FIP oc-
curs mainly in cats living in densely pop-
ulated groups. Release of FCoV seroposi-
tive wildcats into the wild will relieve the
animals from the infectious pressure ex-
perienced while living in a group in cap-
tivity. We speculate that with time the an-
tibody titers and most likely also the FCoV
load will decrease to levels below the de-
tection limit. It would be interesting to
know whether wildcats in which the FCoV
antibodies decrease to an undetectable
level are able to completely get rid of
FCoV or whether the virus can persist
somewhere in the cats’ body.
Antibodies to FCV, FHV, and FPV were
only rarely detected in the European wild-
cat populations. This came as a surprise,
especially in the case of FPV known to be
not only highly contagious but also forms
a reservoir of infection in the domestic cat.
The efficiency of the FPV IFA to detect
antibodies specific for FPV was evaluated
by testing plasma samples from cats vac-
cinated against FPV one year prior to the
IFA. These results indicated, that the test
reliably detects FPV antibodies in the plas-
ma samples. Furthermore, these tests
show that the low prevalence of antibodies
to FPV, FCV, and FHV in the European
wildcat population is real and not due to
insensitive tests.
Lentiviruses related to FIV of domestic
cats have been isolated and described from
a wide variety of species in the family of
the Felidae (Hofmann-Lehmann et al.,
1996; Olmsted et al., 1992; Brown et al.,
1994; Carpenter and O’Brien, 1995; Lutz
et al., 1992). However, it has not yet been
demonstrated that FIV-related viruses
cause disease in species other than the do-
mestic cat (Brown et al., 1994; Lutz et al.,
1992). Similar to investigations made by
other groups (Artois and Remond, 1994;
McOrist et al., 1991; McOrist, 1992), no
evidence for the presence of a European
wildcat-related FIV could be found in the
present study. It has to be considered, that
all these attempts to detect FIV in wildcats
were based on the possible ability of an-
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tibodies to crossreact with FIV antigens
derived from domestic cats. All lentivirus-
es so far detected in wild felids show im-
munological crossreactivity with core pro-
teins of FIV of the domestic cat (Barr et
al., 1995). Therefore, our results exclude
the existence of a wildcat lentivirus closely
related to that of the domestic cat but not
one more closely related to ovine or
equine lentiviruses.
Both free-ranging wildcat populations
showed a high prevalence of FeLV p27 an-
tigen and antibodies to FeLV. From the
results of the immune-coprecipitation it
was concluded, that hemolysis was not re-
sponsible for the positive results of the p27
ELISA and that the high prevalence found
in our study indeed corresponded to a
high prevalence of FeLV infection in the
wildcat population. These results are in
agreement with other studies reporting a
high prevalence of FeLV in different wild-
cat populations (Boid et al., 1991; Mc-
Orist, 1992; Artois and Remond 1994).
The cats of the present study originating
from France (n 5 34) and Switzerland (n
5 9) were all victims of car accidents and
therefore our findings may be biased.
Therefore the true prevalence of FeLV
may have been overestimated. However,
the eight subadult wildcats bred in captiv-
ity and prepared to be released into the
wild also showed a high prevalence of
FeLV antigen and antibodies to FeLV
(FeLV p27 antigen: 50%, FeLV antibodies:
75%) in the absence of clinical signs. Cur-
rently, it is difficult to estimate the disease
potential of FeLV or whether several
strains with different pathogenicity are
present in wildcats. To what extent FeLV
infected wildcats can serve as a reservoir
for domestic cats is unknown; however,
transmission of FeLV from wild to domes-
tic cats could theoretically occur.
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